Search Results
10
Everything
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
April 02, 2025 16:10 ET
|
eXoZymes Inc.
Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies ...
Old National Bancorp Announces Schedule for First-Quarter 2025 Earnings Release and Conference Call
April 02, 2025 16:10 ET
|
Old National Bancorp
EVANSVILLE, Ind., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Old National Bancorp (“Old National”), the holding company of Old National Bank, today announced the following schedule for its...
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
April 02, 2025 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
Marex Completes Acquisition of Aarna Capital as it Expands in the Middle East
April 02, 2025 16:05 ET
|
Marex Group plc
LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc, the diversified global financial services platform, today announces the completion of its acquisition of Aarna Capital Limited (“Aarna...
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
April 02, 2025 16:05 ET
|
Elutia Inc.
Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer...
FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing Demand
April 02, 2025 16:05 ET
|
FormFactor, Inc.
LIVERMORE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies for the semiconductor industry, is pleased to announce...
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
April 02, 2025 16:05 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin...
NeuroPace Announces Refocusing of Product Portfolio
April 02, 2025 16:05 ET
|
NeuroPace, Inc.
-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by...
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
April 02, 2025 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing...
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 02, 2025 16:05 ET
|
FibroGen, Inc.
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place...